Citizens Financial Group Inc Cognition Therapeutics Inc Transaction History
Citizens Financial Group Inc
- $7.13 Billion
- Q3 2025
A detailed history of Citizens Financial Group Inc transactions in Cognition Therapeutics Inc stock. As of the latest transaction made, Citizens Financial Group Inc holds 13,679 shares of CGTX stock, worth $23,938. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,679Holding current value
$23,938% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CGTX
# of Institutions
67Shares Held
19MCall Options Held
0Put Options Held
0-
Bios Capital Management, LP Fort Worth, TX6MShares$10.5 Million9.11% of portfolio
-
Davenport & CO LLC2.69MShares$4.71 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.68MShares$4.69 Million0.0% of portfolio
-
Pathstone Family Office, LLC Englewood, NJ2.21MShares$3.86 Million0.02% of portfolio
-
Geode Capital Management, LLC Boston, MA713KShares$1.25 Million0.0% of portfolio
About COGNITION THERAPEUTICS INC
- Ticker CGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 22,710,700
- Market Cap $39.7M
- Description
- Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is CT1812, a sigma-2 receptor antagonist, which is in Phase II clinical tr...